1320 Eribulin mesylate in metastatic breast cancer, a focus on safety and efficacy in elderly patients. Results from the EVHALAVEN multicentric retrospective cohort. (September 2015) - Martin-babau, J.; Robert, M.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Gourmelon, C.; Brunot, A.; Lefeuvre-plesse, C.; Korenbaum, C.; Petit, T.; Marquis, A.; et al.